Mar 03, 2019|3 min readBy DDNews StaffBiogen eyes Nightstar TherapeuticsBiogen announces agreement to acquire Nightstar Therapeutics to establish clinical pipeline of gene therapy candidates in ophthalmology
Apr 10, 2019|3 min readBy Mel J. YeatesBiogen buys into ophthalmologyCompany announces agreement to acquire Nightstar Therapeutics
Nov 12, 2018|4 min readBy Mel J. YeatesBiogen boosts multiple sclerosis researchEvidence supports serum neurofilament light as useful biomarker; Biogen and Siemens to develop blood test
Oct 07, 2020|5 min readBy Kevin NoonanInterplay between obviousness and satisfaction invalidates claims in Biogen Tecfidera patentThe same evidence that supports non-obviousness for patentability can also restrict the scope of what has been described
Aug 01, 2019|2 min readBy DDNews StaffFujifilm acquires new Denmark manufacturing facilityFujifilm completes acquisition of Biogen’s manufacturing site in Denmark
Aug 13, 2019|3 min readBy DDNews StaffAdding value for CDMO clientsFujifilm completes acquisition of Biogen’s manufacturing site in Denmark
Mar 09, 2016|3 min readBy Lloyd DunlapBiogen kicks off ALS funding challengeWith an initial $5-million donation, goal for Biogen and Target ALS is $20 million more in corporate funding
Sep 24, 2006|1 min readBy Randall C WillisBiogen, Alnylam target CNS diseaseTargeting progressive multifocal leukoencephalopathy (PML)
Apr 21, 2018|3 min readBy DDNews StaffBiogen and Ionis agree to ten-year collaborationBiogen and Ionis expand strategic collaboration to develop drug candidates for a broad range of neurological diseases
Sep 10, 2013|2 min readBy Kelsey KaustinenBiogen Idec, Isis strike fourth collaborationCompanies to use antisense technology to develop treatments for neurological disease